Article
ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms do not affect methadone maintenance treatment in HCV-positive patients.
Arhiv za higijenu rada i toksikologiju - 31 Dec 2020
Sutlović Davorka, Ključević Željko, Kuret Sendi
Abstract excerpt
The aim of this study was to determine the influence of ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms on methadone metabolism in patients with hepatitis C virus (HCV) undergoing methadone maintenance treatment (MMT). The study included 35 participants undergoing MMT, who were divided in three groups: HCV-positive (N=12), HCV-negative (N=16), and HCV clinical remission (CR) (N=7). The concentrations of methadone...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
